AZRG:TASEAzrieli Group Ltd. Analysis
Data as of 2026-03-11 - not real-time
ILA 47,040.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Azrieli Group Ltd. (AZRG.TA) is trading at 47,040 ILA, comfortably above its 20‑day SMA (46,455) and 50‑day SMA (43,402), indicating short‑term momentum, while the 30‑day volatility sits near 41%, suggesting price swings can be sizable. The RSI of 55.8 places the stock in a neutral zone, and the MACD shows a bearish histogram (‑46) with the line below its signal, hinting at potential downside pressure despite the bullish trend direction. Sentiment is extremely positive, reflected by a Fear & Greed Index of 77 (Extreme Greed), yet the upside/downside projection is –8.3%, implying limited upside ahead.
Fundamentally, the company commands a high P/E of 34.7 versus an industry average of 32.6 and an astronomically elevated P/B of 230, signaling that the market is pricing in strong growth expectations that may be hard to justify. Margins are solid (gross 68%, operating 57%), but free cash flow is negative (‑555 M) and debt‑to‑equity is steep at 119%, raising concerns about leverage and dividend sustainability, especially with a payout ratio of 48.8% and a modest 1.4% yield. Overall, the stock appears overvalued, with growth expectations outpacing cash generation, and investors should weigh the strong market momentum against the fundamental headwinds.
Fundamentally, the company commands a high P/E of 34.7 versus an industry average of 32.6 and an astronomically elevated P/B of 230, signaling that the market is pricing in strong growth expectations that may be hard to justify. Margins are solid (gross 68%, operating 57%), but free cash flow is negative (‑555 M) and debt‑to‑equity is steep at 119%, raising concerns about leverage and dividend sustainability, especially with a payout ratio of 48.8% and a modest 1.4% yield. Overall, the stock appears overvalued, with growth expectations outpacing cash generation, and investors should weigh the strong market momentum against the fundamental headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above 20‑day SMA supporting short‑term momentum
- Bearish MACD histogram suggesting possible pullback
- Increasing volume indicating active trading interest
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Overvaluation indicated by P/B of 230 and P/E above industry
- High leverage (debt‑to‑equity 119%) and negative free cash flow
- Stable dividend yield but sustainability concerns
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Fundamental overvaluation with limited upside potential
- Elevated debt levels and cash flow deficits
- Dividend sustainability risk amid weak cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth16.00%
Profit Margin43.66%
P/E Ratio34.7
ROE6.80%
ROA2.27%
Debt/Equity119.50
P/B Ratio230.3
Op. Cash FlowILA1.8B
Free Cash FlowILA-555000000
Industry P/E32.6
Technical Analysis
TrendBullish
RSI55.8
SupportILA 42,850.00
ResistanceILA 50,600.00
MA 20ILA 46,455.50
MA 50ILA 43,402.00
MA 200ILA 33,922.90
MACDBearish
VolumeIncreasing
Fear & Greed Index77.18
Valuation
Fair ValueILA 6,066.60
Target PriceILA 43,150.00
Upside/Downside-8.27%
GradeOvervalued
TypeBlend
Dividend Yield1.40%
Risk Assessment
Beta0.11
Volatility40.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.